Neumann J, Schmidt F, Hofmann B, Gergs U
Int J Mol Sci. 2025; 26(2.
PMID: 39859412
PMC: 11765814.
DOI: 10.3390/ijms26020698.
Kupnicka P, Krol M, Zychowska J, Lagowski R, Prajwos E, Surowka A
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598383
PMC: 11597758.
DOI: 10.3390/ph17111470.
Nakashima M, Suga N, Yoshikawa S, Matsuda S
Molecules. 2024; 29(16).
PMID: 39203005
PMC: 11357136.
DOI: 10.3390/molecules29163922.
Reed J, Bain S, Kanamarlapudi V
Diabetes Metab Syndr Obes. 2024; 17:2419-2456.
PMID: 38894706
PMC: 11184168.
DOI: 10.2147/DMSO.S415934.
Puddu A, Maggi D
Int J Mol Sci. 2024; 25(4).
PMID: 38396675
PMC: 10888676.
DOI: 10.3390/ijms25041997.
The Effects of a High-Carbohydrate versus a High-Fat Shake on Biomarkers of Metabolism and Glycemic Control When Used to Interrupt a 38-h Fast: A Randomized Crossover Study.
Deru L, Gipson E, Hales K, Bikman B, Davidson L, Horne B
Nutrients. 2024; 16(1).
PMID: 38201992
PMC: 10780935.
DOI: 10.3390/nu16010164.
Evolution of GCGR family ligand-receptor extensive cross-interaction systems suggests a therapeutic direction for hyperglycemia in mammals.
Liu J, Wang X, Zhang W, Liao G, Shao Z, Brosius J
Acta Biochim Biophys Sin (Shanghai). 2023; 55(12):1855-1863.
PMID: 37969012
PMC: 10753361.
DOI: 10.3724/abbs.2023133.
Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities.
Xie Y, Wang Y, Pei W, Chen Y
Front Mol Biosci. 2023; 10:1210347.
PMID: 37780209
PMC: 10540701.
DOI: 10.3389/fmolb.2023.1210347.
The past, present, and future physiology and pharmacology of glucagon.
Capozzi M, DAlessio D, Campbell J
Cell Metab. 2022; 34(11):1654-1674.
PMID: 36323234
PMC: 9641554.
DOI: 10.1016/j.cmet.2022.10.001.
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance.
Sharma A, Virmani T, Sharma A, Chhabra V, Kumar G, Pathak K
Diabetes Metab Syndr Obes. 2022; 15:1845-1864.
PMID: 35733643
PMC: 9208633.
DOI: 10.2147/DMSO.S369712.
Exendin-4 as a Versatile Therapeutic Agent for the Amelioration of Diabetic Changes.
Rajabi H, Ahmadi M, Aslani S, Saberianpour S, Rahbarghazi R
Adv Pharm Bull. 2022; 12(2):237-247.
PMID: 35620334
PMC: 9106955.
DOI: 10.34172/apb.2022.025.
Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus.
Yaribeygi H, Atkin S, Montecucco F, Jamialahmadi T, Sahebkar A
Biomed Res Int. 2021; 2021:8163153.
PMID: 34471642
PMC: 8405289.
DOI: 10.1155/2021/8163153.
Glucagon-like peptide-1 attenuated carboxymethyl lysine induced neuronal apoptosis via peroxisome proliferation activated receptor-γ.
Zhang H, Song B, Zhu W, Liu L, He X, Wang Z
Aging (Albany NY). 2021; 13(14):19013-19027.
PMID: 34326274
PMC: 8351674.
DOI: 10.18632/aging.203351.
Synthesis and anti-diabetic activity of novel biphenylsulfonamides as glucagon receptor antagonists.
Lee C, Choi H, Park E, Nguyen T, Maeng H, Mee Lee K
Chem Biol Drug Des. 2021; 98(5):733-750.
PMID: 34310065
PMC: 9291748.
DOI: 10.1111/cbdd.13928.
Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor.
Liu J, Sun Y, Zheng H, Wang J, Liu L, Song B
Biomed Res Int. 2021; 2021:6662704.
PMID: 34159197
PMC: 8187071.
DOI: 10.1155/2021/6662704.
Emerging Role of Caveolin-1 in GLP-1 Action.
Puddu A, Maggi D
Front Endocrinol (Lausanne). 2021; 12:668012.
PMID: 33935978
PMC: 8079975.
DOI: 10.3389/fendo.2021.668012.
The Human Islet: Mini-Organ With Mega-Impact.
Walker J, Saunders D, Brissova M, Powers A
Endocr Rev. 2021; 42(5):605-657.
PMID: 33844836
PMC: 8476939.
DOI: 10.1210/endrev/bnab010.
The Neurotrophic Function of Glucagon-Like Peptide-1 Promotes Human Neuroblastoma Differentiation via the PI3K-AKT Axis.
Yang J, Lin Y, Chen W, Yang Y, Sun S, Chen S
Biology (Basel). 2020; 9(11).
PMID: 33105690
PMC: 7690389.
DOI: 10.3390/biology9110348.
Repositioning the Alpha Cell in Postprandial Metabolism.
El K, Capozzi M, Campbell J
Endocrinology. 2020; 161(11).
PMID: 32964214
PMC: 7899437.
DOI: 10.1210/endocr/bqaa169.
Multiagonist Unimolecular Peptides for Obesity and Type 2 Diabetes: Current Advances and Future Directions.
Hasib A
Clin Med Insights Endocrinol Diabetes. 2020; 13:1179551420905844.
PMID: 32110131
PMC: 7025423.
DOI: 10.1177/1179551420905844.